Top Rated Posters
Among all accepted abstracts, the ECCMID Programme Committee has selected 24 outstanding abstracts to be recognised as the top rated posters for the congress.
The presenting authors of these abstracts have been informed on 26.01.2022.
Top Rated Posters (Online & Paper Posters) will be recognizable by the ribbon they have attached.
(logo for Online Posters & physical ribbon for Paper Posters onsite).
ePosters will be accessible through the ECCMID online platform after 13.04.2022 (if uploaded on time).
P0194: Validation of new infection definitions in assessing evidence of infection in patients with suspected sepsis
Author
Lisa MELLHAMMAR* (1), Sixten ELÉN (1), Simone EHRHARD (2), Hjalmar BOUMA (3, 4), Lorenz NINCK (2), Eva MUNTJEWERFF (4), Daniel WÜNSCH (5), Frank BLOOS (5), Erik MALMSTRÖM (1), Adam LINDER (1)
Affiliation
(1) Department of Clinical Sciences, Division of Infection Medicine, Lund University, Sweden, (2) Department of Emergency Medicine, University Hospital Bern, Switzerland, (3) Dept. of Internal Medicine, University Medical Center Groningen, Netherlands, (4) Dept. of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Netherlands, (5) Department of Anesthesiology and Intensive Care Medicine, University Hospital, Germany
P0213: Efficacy of tebipenem pivoxil hydrobromide in patients with complicated urinary tract infection and associated bacteraemia
Authors
Angela K. TALLEY* (1), Paul B. ECKBURG (1), Ian CRITCHLEY (1), Gary MOORE (2), Nivedita BHATT (1), Lori MUIR (1), Aaron DANE (3), David MELNICK (1)
Affiliations
(1) Spero Therapeutics, United States, (2) Moore Computing Services, Inc., United States, (3) DaneStat Consulting, United Kingdom
P0385: Identification of new pneumococcal virulence genes in a larval zebrafish meningitis model
Authors
Rutger KONING* (1), Kin Ki JIM (2, 1), Valery JASPERS (3), Christina VANDENBROUCKE-GRAULS (4), Matthijs BROUWER (1), Diederik VAN DE BEEK (1)
Affiliations
(1) Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands, Netherlands, (2) Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands - Amsterdam (Netherlands), Netherlands, (3) Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands - Amsterdam (Netherlands), Netherlands, (4) Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands, Netherlands
P0400: Long-term outcomes after bacterial meningitis during infancy in Denmark and the Netherlands: national matched cohort study
Authors
Linde SNOEK* (1), Bronner P GONÇALVES (2, 3), Erzsébet HORVÁTH-PUHÓ (4), Merel N VAN KASSEL (1), Simon R PROCTER (2, 3), Kristine K SØGAARD (4, 5), Jaya CHANDNA (2, 3), Arie VAN DER ENDE (6), Diederik VAN DE BEEK (1), Matthijs C BROUWER (1), Henrik T SØRENSEN (4), Joy E LAWN (2, 3), Merijn W BIJLSMA (1, 7)
Affiliations
(1) Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Netherlands, (2) Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, United Kingdom, (3) Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom, (4) Department of Clinical Epidemiology, Aarhus University, Denmark, (5) Department of Clinical Microbiology, Aalborg University Hospital, Denmark, (6) Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam UMC/RIVM, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity, Netherlands, (7) Department of Paediatrics, Amsterdam UMC, University of Amsterdam, Netherlands
P0444: Sequencing of all initial patient isolates of vancomycin-resistant Enterococcus faecium (VREfm) from 2020 shows alarming emergence of the new strain ST1299/CT1903/vanA
Authors
Anca RATH*, Bärbel KIENINGER, Jürgen FRITSCH, Aila CAPLUNIK-PRATSCH, Nilufarbayim MIRZALIYEVA, Thomas HOLZMANN, Wulf SCHNEIDER-BRACHERT
Affiliations
Department of Infection Prevention and Infectious Diseases, University Hospital Regensburg, Germany
P0615: Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales
Authors
Juan Carlos VÁZQUEZ-UCHA*, Cristina LASARTE-MONTERRUBIO, Paula GUIJARRO-SÁNCHEZ, Laura ÁLVAREZ-FRAGA, Isaac ALONSO-GARCÍA, Marta MARTÍNEZ-GUITIÁN, Jorge ARCA-SUÁREZ, Germán BOU, Alejandro BECEIRO
Affiliation
Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain., Spain
P0624: In vitro activity of aztreonam-avibactam and comparator agents against metallo-β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected in emerging market countries during the ATLAS global surveillance programme in 2019-
Authors
Krystyna KAZMIERCZAK* (1), Mark ESTABROOK (1), Tarun MATHER (2), Francis ARHIN (3), Alvaro QUINTANA (4), Shweta KAMAT (5), Daniel SAHM (1)
Affiliations
(1) IHMA, United States, (2) IHMA, India, (3) Pfizer, Inc., Canada, (4) Pfizer, Inc., United States, (5) Pfizer, Inc., India
P0675: In vitro activities of aztreonam-avibactam and comparator agents against metallo-β-lactamase-producing Enterobacterales collected during the ATLAS global surveillance program, 2016-2020
Authors
Mark WISE* (1), Mark ESTABROOK (1), Francis ARHIN (2), Daniel SAHM (1)
Affiliations
(1) IHMA, United States, (2) Pfizer, Inc, Canada
P0752: Development of EUCAST MIC and zone diameter clinical breakpoints for Vibrio spp.
Authors
Onur KARATUNA*, Erika MATUSCHEK, Jenny ÅHMAN, Gunnar KAHLMETER
Affiliation
EUCAST Development Laboratory, Sweden
P0766: The EUCAST rapid antimicrobial susceptibility testing method directly from positive blood culture bottles: extending the incubation to 16-24 hours for five important sepsis pathogens
Authors
Emma JONASSON* (1), Erika MATUSCHEK (2), Gunnar KAHLMETER (2)
Affiliations
(1) Department of Clinical Microbiology, Central Hospital, Sweden, (2) EUCAST Development Laboratory, Sweden
P0779: EUCAST disk diffusion criteria for clinically important, commonly isolated, and rapidly growing anaerobic bacteria: correlations between inhibition zone diameters and agar dilution MICs on Fastidious Anaerobe Agar
Authors
Erika MATUSCHEK* (1), Sarah COPSEY-MAWER (2), Sara PETERSSON (3), Jenny ÅHMAN (1), Trefor MORRIS (2), Gunnar KAHLMETER (1)
Affiliations
(1) EUCAST Development Laboratory, Sweden, (2) UK Anaerobe Reference Unit, United Kingdom, (3) Clinical Microbiology, Sweden
P0842: Evolution of ß-lactamase mediated cefiderocol resistance
Authors
Christopher FRÖHLICH (1), Vidar SØRUM* (1), Nobuhiko TOKURIKI (2), Ørjan SAMUELSEN (1, 3)
Affiliations
(1) University of Tromsø, Norway, (2) University of British Columbia, Canada, (3) University Hospital of North Norway, Norway
P0876: New divergent beta-lactamases in candidate phyla radiation: owning pleiotropic enzymes is a smart paradigm for microorganisms with reduced genome
Authors
Mohamad MAATOUK*, Ahmad IBRAHIM, Lucile PINAULT, Nicholas ARMSTRONG, Said AZZA, Jean-Marc ROLAIN, Didier RAOULT, Fadi BITTAR
Affiliations
IHU Méditerranée Infection, Marseille, France, France
P0939: Large-scale One Health genomic survey of third-generation cephalosporin- and carbapenem-resistant Enterobacteriaceae in Thailand
Authors
Natacha COUTO* (1), Marjorie GIBBON (1), Keira COZENS (1), Punyawee DULYAYANGKUL (2), Nisanart CHAROENLAP (3), Skorn MONGKOLSUK (3), Nuchanart RANGKADILOK (3), Jutamaad SATAYAVIVAD (3), Kwanrawee SIRIKANCHANA (3), Tawit SURIYO (3), Boonrat CHANTONG (4), Aronrag MEEYAI (4), Varapon MONTRIVADE (4), Kornrawan PHOONSAWAD (4), Walasinee SAKCAMDUANG (4), Luechai SRINGERNYUANG (4), Sarin SUWANPAKDEE (4), Kantima WICHUWARANAN (4), Anuwat WIRATSUDAKUL (4), Parntep RATANAKORN (4), Nour ALHUSEIN (2), Ross D BOOTON (2), Virginia C GOULD (2), Helen LAMBERT (2), Kristen K REYHER (2), Hannah SCHUBERT (2), Katherine M E TURNER (2), Lucy VASS (2), Henry BULLER (5), Emma PITCHFORTH (5), Andrew C SINGER (6), Greco Mark MALIJAN (7), Visanu THAMLIKITKUL (4), Matthew B AVISON (2), Ed J FEIL (1)
Affiliations
(1) University of Bath, United Kingdom, (2) University of Bristol, United Kingdom, (3) Chulabhorn Research Institute, Thailand, (4) Mahidol University, Thailand, (5) University of Exeter, United Kingdom, (6) UK Centre for Ecology & Hydrology, United Kingdom, (7) University of Oxford, United Kingdom
P0975: Tracing of colistin-resistant Enterobacteriaceae in Belgian and Dutch hospitals and livestock farms using a One Health approach: a longitudinal study
Authors
Sien DE KOSTER* (1), Basil Britto XAVIER (1), Christine LAMMENS (1), Natascha PERALES SELVA (2), Stefanie VAN KLEEF-VAN KOEVERINGE (2), Isabel LEROUX-ROELS (3), Jeroen DEWULF (4), Arjan STEGEMAN (5), Marjolein KLUYTMANS-VAN DEN BERGH (6, 7, 8), Jan KLUYTMANS (6, 8, 9), Herman GOOSSENS (1, 2)
Affiliations
(1) Laboratory of Medical Microbiology, Vaccine and Infectious Diseases Institute, University of Antwerp, Belgium, (2) Laboratory of Medical Microbiology, University Hospital Antwerp, Belgium, (3) Department of Laboratory Medicine, Ghent University Hospital, Belgium, (4) Veterinary Epidemiology Unit, Department of Internal medicine, reproduction and population medicine, Faculty of Veterinary Medicine, Ghent University, Belgium, (5) Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Netherlands, (6) Department of Infection Control, Amphia Hospital, Netherlands, (7) Amphia Academy Infectious Disease Foundation, Amphia Hospital, Netherlands, (8) Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands, (9) Microvida Laboratory for Microbiology, Amphia Hospital, Netherlands
P1262: Simultaneously inactivating three or all four penicillin-binding proteins (PBPs) among PBP1a, 1b, 2 and 3 synergistically kills Acinetobacter baumannii (AB)
Authors
Carolin WERKMAN* (1), Nirav SHAH (1), Deanna DEVESON LUCAS (2), Jeremiah OYER (3), Marianne MEGROZ (2), Bartolome MOYA (4), Alaa SAYED (1), Abeer ELSAYED (1), Amy WRIGHT (2), Dhruvitkumar SUTARIA (1), Xun TAO (1), Yinzhi LANG (1), Jieqiang ZHOU (1), Eunjeong SHIN (1), Cornelia LANDERSDORFER (2), Rossie JIMENEZ-NIEVES (1), Keisha CADET (1), Yuanyuan JIAO (1), Alicja COPIK (3), Robert BONOMO (5), Arnold LOUIE (1), George DRUSANO (1), John BOYCE (2), Jürgen BULITTA (1)
Affiliations
(1) University of Florida, United States, (2) Monash University, Australia, (3) University of Central Florida, United States, (4) Institut d Investigacio Sanitaria illes Balears, Spain, (5) Case Western Reserve University, United States
P1670: Rapid identification of Staphylococcus aureus carriers before hip hemiarthroplasty for femur fracture: does it help prevent prosthetic joint infections?
Authors
Nerea ROCH (1), Julio DE CASO (2), Alba RIVERA (3), Mireia PUIG (4), Virginia POMAR (1), Elena GÓMEZ (2), Raul ALTABA (3), Alberto COZAR (1), Tania NOLLA (2), Daniela MINIAC (3), Engracia FERNÁNDEZ (1), Marcos JORDÁN (2), Ana Pilar CORTÉS (1), Marta PÍRIZ (1), Xavier CRUSI (2), Joaquín LÓPEZ-CONTRERAS (5), Natividad BENITO* (5)
Affiliations
(1) Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Spain, (2) Department of Orthopaedic Surgery and Traumatology, Hospital de la Santa Creu i Sant Pau, Spain, (3) Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Spain, (4) Department of Emergency, Hospital de la Santa Creu i Sant Pau, Spain, (5) Infectious Diseases Unit, Spain
P1744: Predicting hospital-onset COVID-19 infections using dynamic networks of patient contacts: an observational study
Authors
Ashleigh MYALL* (1), Price JAMES (2), Peach ROBERT (1), Abbas MOHAMED (1), Mookerjee SIDDHARTH (2), Zhu NINA (1), Ahmed ISA (1), Ming DAMIEN (1), Ramzan FARZAN (1), Teixeira DANIEL (3), Graf CHRISTOPHE (3), Weiße ANDREA (4), Harbarth STEPHAN (3), Holmes ALISON (1), Barahona MAURICIO (1)
Affiliations
(1) Imperial College London, United Kingdom, (2) Imperial College NHS Trust, United Kingdom, (3) Hôpitaux Universitaires de Genève, Switzerland, (4) The University of Edinburgh, United Kingdom
P1802: The dose-dependent association of cumulative exposure to COVID-19 patients with risk of SARS-CoV-2 infection in healthcare workers and the modulating effect of respirator versus surgical mask use
Authors
Tamara DÖRR* (1), Sabine HALLER (1), Thomas EGGER (1), Onicio LEAL-NETO (2, 3), Domenica FLURY (1), Angela BRUCHER (4), Eva LEMMENMEIER (5), Carsten MÖLLER (6), Philip RIEDER (7), Markus RUETTI (8), Reto STOCKER (7), Danielle VUICHARD-GYSIN (9, 10), Benedikt WIGGLI (11), Ulrike BESOLD (12), Allison MC GEER (13), Lorenz RISCH (14, 15, 16), Andree FRIEDL (11), Dorette MEIER KLEEB (17), Hans-Ruedi SCHMID (18), Pietro VERNAZZA (1), Matthias SCHLEGEL (1), Stefan P. KUSTER (1), Christian R. KAHLERT (1, 19), Philipp KOHLER (1)
Affiliations
(1) Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland, Switzerland, (2) Epitrack, Brazil, (3) Department of Economics, University of Zurich, Zurich, Switzerland, Switzerland, (4) Psychiatry Services of the Canton of St. Gallen (South), Switzerland, Switzerland, (5) Clienia Littenheid AG, Private Clinic for Psychiatry and Psychotherapy, Littenheid, Switzerland, Switzerland, (6) Center for Neurological Rehabilitation, Zihlschlacht, Switzerland, Switzerland, (7) Hirslanden Clinic, Zurich, Switzerland, Switzerland, (8) Hospital Region Fürstenland Toggenburg, Wil, Switzerland, Switzerland, (9) Thurgau Hospital Group, Division of Infectious Diseases and Hospital Epidemiology, Muensterlingen, Switzerland, Switzerland, (10) Swiss National Centre for Infection Prevention (Swissnoso), Berne, Switzerland, Switzerland, (11) Cantonal Hospital Baden, Division of Infectious Diseases and Hospital Epidemiology, Baden, Switzerland, Switzerland, (12) Geriatric Clinic St. Gallen, St. Gallen, Switzerland, Switzerland, (13) Sinai Health System, Toronto, Canada, Canada, (14) Labormedizinisches Zentrum Dr Risch Ostschweiz AG, Buchs, Switzerland, Switzerland, (15) Private Universität im Fürstentum Liechtenstein,, Liechtenstein, (16) Centre of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Inselspital, Bern, Switzerland, Switzerland, (17) Cantonal Hospital Baden, Division of Occupational Health, Baden, Switzerland, Switzerland, (18) Cantonal Hospital Baden, Central Laboratory, Baden, Switzerland, Switzerland, (19) Children's Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital Epidemiology, St. Gallen, Switzerland, Switzerland
P1816: Comparison of virulence factors in colonising and infecting Klebsiella pneumoniae isolates obtained from a German multi-centre surveillance study
Authors
Kai LUCAßEN* (1), Kyriaki XANTHOPOULOU (1, 2), Julia WILLE (1, 2), Sarah V. WALKER (1), Vivien PERSY (1, 2), David TOBYS (1, 2), Harald SEIFERT (1, 2), Paul G. HIGGINS (1, 2)
Affiliations
(1) Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany, (2) German Center for Infection Research (DZIF), Partner Site Bonn-Cologne,, Germany
P1857: A deep look at the vaginal environment during pregnancy and puerperium
Authors
Claudio FOSCHI (1), Marco SEVERGNINI (2), Sara MORSELLI* (1), Tania CAMBONI (2), Camilla CECCARANI (2), Luca LAGHI (3), Sara ZAGONARI (4), Giulia PATUELLI (4), Maria Federica PEDNA (5), Vittorio SAMBRI (5), Clarissa CONSOLANDI (2), Antonella MARANGONI (1)
Affiliations
(1) Microbiology, DIMES, University of Bologna, Italy, (2) Institute of Biomedical Technologies – National Research Council, Segrate, Italy, (3) Centre of Foodomics, Department of Agro-Food Science and Technology, University of Bologna,, Italy, (4) Family Advisory Health Centres, Italy, (5) Unit of Microbiology, Greater Romagna Hub Laboratory, Pievesestina di Cesena, Italy
P2245: Safety, tolerability, and immunogenicity of a booster dose of BNT162b2 COVID-19 vaccine co-administered with 20-valent pneumococcal conjugate vaccine (PCV20) in adults 65-years of age and above
Authors
David FITZ-PATRICK (1), Timothy JENNINGS (2), Mariano YOUNG* (3), Kari YACISIN (3), Kathleen MCELWEE (3), Todd BELANGER (3), Kelly BELANGER (3), Yahong PENG (3), Dung-Yang LEE (3), William C GRUBER (3), Daniel A SCOTT (3), Wendy WATSON (3)
Affiliations
(1) East-West Medical Research Institute, United States, (2) Clinical Research Professionals, United States, (3) Vaccine Research and Development, Pfizer Inc, United States
P2297: Theory of the epidemic process: new Russian approach
Authors
Grigory KAMINSKIY* (1), Eduard KARAMOV (2), Juriy PROSTOV (3), Oleg ZATSEPIN (4), Sergej LEBEDEV (4)
Affiliations
(1) National Medical Research Center of Phthisiopulmonology and Infectious Diseases» of the Ministry of Health of the Russian Federation, Russian Federation, (2) N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, Russian Federation, (3) Research Institute for Healthcare and Medical Management of Moscow Healthcare Department, Russian Federation, (4) Russian Federal Nuclear Center – Zababakhin All-Russia Research Institute of Technical Physics, Russian Federation
P2304: Risk factors associated with environmental contamination by SARS-CoV-2 surround patients with COVID-19
Authors
Jun-Won SEO*, Da Young KIM, Na Ra YUN, You Mi LEE, Merlin Jayalal LAWRENCE PANCHALI, Mi-Seon BANG, Seong Yeon HWANG, Choon-Mee KIM, Dong-Min KIM
Affiliation
Department of Internal Medicine, College of Medicine, Chosun University, Korea, Republic of
